Febentel 444 mg

Fenbendazole is being investigated because laboratory studies have identified several ways it can affect abnormal cells. Its potential research benefits include:

• Disrupting cancer-cell division

• Interfering with microtubule formation

• Reducing glucose uptake by cancer cells

• Affecting cellular energy production

• Influencing proteins involved in damaged cells

• Supporting research into repurposed compounds

A 2018 laboratory study reported activity against human cancer cells and reduced tumour growth in an experimental mouse model. Research has continued in other preclinical cancer models, including recent breast and cervical cancer studies. These findings support further investigation but do not confirm a benefit for cancer patients.

A computational SARS-CoV-2 study also included fenbendazole when examining possible binding to spike proteins from the Alpha and Gamma variants. Computer-predicted binding is an early research finding. It does not demonstrate that fenbendazole prevents COVID-19, stops viral replication or improves recovery.

Fenbendazole interferes with a protein called beta-tubulin. This prevents susceptible parasites from forming microtubules, which are tiny structures needed for transporting nutrients and maintaining normal cell functions.

Without working microtubules, parasites cannot absorb and use glucose properly. Their energy stores become depleted, leading to their death.

Cancer cells also use microtubules when they divide. Laboratory studies found that fenbendazole disrupted these structures and affected glucose uptake and energy production in cancer cells. Researchers have also observed changes involving p53, a protein that helps control damaged or abnormal cells.

For COVID-19 research, scientists used computer simulations to predict whether fenbendazole could interact with SARS-CoV-2 spike proteins. These simulations describe a possible molecular interaction and do not show what happens after the tablet is taken by a person.

There is no established human dosage of Febentel 444 mg for cancer or COVID-19. The 444 mg printed on the packaging describes the amount of fenbendazole in each tablet. It is not a recommended human treatment dose.

Veterinary dosing depends on the animal species, body weight, parasite and product instructions. A qualified veterinary professional should determine the correct amount and treatment schedule.

Online protocols sometimes recommend taking fenbendazole daily, in repeated cycles or with vitamins and supplements. These schedules have not been validated through controlled human trials. The higher amount in a 444 mg tablet does not establish stronger cancer or antiviral activity.

Do not choose a dose from online testimonials or another person’s experience. Anyone considering or already using fenbendazole should inform the appropriate medical team about the product, strength, amount and frequency. Prescribed cancer or COVID-19 treatment should not be stopped, delayed or changed.

Common Side Effects: Reliable information about common side effects in people is unavailable because fenbendazole has not completed adequate controlled human safety studies. Digestive discomfort, nausea, diarrhoea, allergic reactions and changes in liver-test results have been reported or discussed, but their frequency in people is unknown.

Serious Side Effects: Published human case reports have linked self-administered fenbendazole with drug-induced liver injury. Warning signs include yellow skin or eyes, dark urine, pale stools, persistent nausea, loss of appetite, unusual tiredness and pain in the upper-right abdomen. Stop taking the product and obtain prompt medical attention if these symptoms develop.

Febentel 444 mg should not be used for human self-treatment. Particular concern applies to:

• People with liver disease

• People with abnormal liver tests

• People receiving chemotherapy

• People receiving immunotherapy

• People using targeted cancer medicines

• Pregnant or breastfeeding women

• Children and adolescents

• People allergic to benzimidazoles

• People enrolled in clinical trials

• People self-treating COVID-19

Human interaction studies for fenbendazole are limited. Tell the healthcare team about every medicine, supplement and herbal product being used.

Important combinations requiring medical review include:

• Chemotherapy medicines

• Immunotherapy medicines

• Targeted cancer treatments

• Prescribed COVID-19 antivirals

• Liver-affecting medicines

• Other benzimidazole medicines

• Herbal remedies and supplements

Taking an undisclosed product can make it harder to determine whether abnormal test results or side effects are caused by fenbendazole or the prescribed treatment. This is particularly important when liver inflammation is already a known risk of the recognised medicine.

• Keep the tablets in their original packaging.

• Follow the storage temperature printed on the pack.

• Store in a cool and dry place.

• Protect from moisture and direct sunlight.

• Keep away from children and pets.

• Do not use damaged or discoloured tablets.

• Check the batch number and expiry date.

• Dispose of expired tablets according to local requirements.